TheBrief.Health

Wrap-Up: Vyvgart Targets Four Populations at AAN 2026


Listen Later

AAN 2026 highlights transformative ADAPT data, expanding Vyvgart across MG subtypes and CIDP, signaling targeted biologics, pediatric advances, and urgent updates to managed care coverage frameworks.
...more
View all episodesView all episodes
Download on the App Store

TheBrief.HealthBy TheBrief.Health